Case Type: Mergers & Acquisitions

eMagin Corp. (NYSE: EMAN), relating to its proposed sale to Samsung Display Co., Ltd. Under the terms of the agreement, EMAN shareholders are expected to receive $2.08 in cash per share they own.

Chase Corp. (NYSE: CCF), relating to its proposed sale to an affiliate of investment funds managed by KKR. Under the terms of the agreement, CCF shareholders are expected to receive $127.50 in cash per share they own.

Heritage-Crystal Clean, Inc. (Nasdaq: HCCI), relating to its proposed sale to an affiliate of J.F. Lehman & Co. Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.

Neoleukin Therapeutics, Inc. (Nasdaq: NLTX), relating to its proposed merger with Neurogene Inc. Under the terms of the agreement, NLTX shareholders are expected to own approximately 16% of the combined company.

Sculptor Capital Management Inc. (NYSE: SCU), relating to its proposed sale to Rithm Capital Corp. Under the terms of the agreement, Class A SCU shareholders are expected to receive $11.15 in cash per share they own.

Pardes Biosciences, Inc. (Nasdaq: PRDS), relating to its proposed sale to MediPacific, Inc. Under the terms of the agreement, PRDS shareholders are expected to receive at least $2.02 plus an additional cash amount of at most $0.17 in cash per share they own, as well as one non-tradeable CVR.

Sigilon Therapeutics, Inc. (Nasdaq: SGTX), relating to its proposed sale to Eli Lilly and Co. Under the terms of the agreement, SGTX shareholders are expected to receive $14.92 in cash per share they own plus one contingent value right worth up to $111.64.

Immunome, Inc. (Nasdaq: IMNM), relating to its proposed merger with Morphimmune.

Great Ajax Corp. (NYSE: AJX), relating to its proposed sale to Ellington Financial Inc. Under the terms of the agreement, AJX shareholders are expected to receive 0.5308 shares of Ellington per share they own.

American Equity Investment Life Holding Co. (NYSE: AEL), relating to its proposed sale to Brookfield Reinsurance. Under the terms of the agreement, AEL shareholders are expected to receive 0.49707 shares of Brookfield and $38.85 in cash per share they own.